one apatite contains carbonate and is therefore not pure hydroxyapatite. We have successfully developed sintered carbonate apatite (CA) with a concentration of carbonate of 6 weight% and have evaluated its osteoconductive and bioresorption characteristics. Cylindrical porous sintered CA and sintered hydroxyapatite (HA) measuring 4 x 4 mm with a porosity of 20% were implanted into surgicallycreated bone defects in the knees of rabbits. The animals were killed after 1, 3, 6 and 12 months. The defects were evaluated by microfocus CT and histology.
one apatite contains carbonate and is therefore not pure hydroxyapatite. We have successfully developed sintered carbonate apatite (CA) with a concentration of carbonate of 6 weight% and have evaluated its osteoconductive and bioresorption characteristics. Cylindrical porous sintered CA and sintered hydroxyapatite (HA) measuring 4 x 4 mm with a porosity of 20% were implanted into surgicallycreated bone defects in the knees of rabbits. The animals were killed after 1, 3, 6 and 12 months. The defects were evaluated by microfocus CT and histology.
Bone growth into and around both materials increased. Newly-formed bone was placed in direct contact with both. Osteoclast-like cells resorbed only CA, and were coupled with osteoblasts. The porosity of sintered CA increased, indicating bioresorption, whereas that of sintered HA did not increase. Our findings indicate that sintered CA may be useful as a bioresorbable bone substitute. [Br] 2003;85-B:142-7.
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Calcium phosphate can be used either as a prosthesis for permanent substitution or as a scaffold in regeneration of bone. When used as a prosthesis such as in a vertebral body or as a substitute for a dental root, the material should not be resorbed, but when required as a scaffold to fill a bone defect, it should be able to be replaced by newly-formed bone. Hydroxyapatite (HA) has been widely used as a bone substitute because of its excellent biocompatibility and osteoconductive ability, but its clinical application may be lim-B ited because it does not seem to be appreciably resorbed. 1 There is conflicting evidence regarding its bioresorption, [2] [3] [4] [5] [6] [7] [8] [9] [10] but the HA used has not always been phase pure and therefore contained resorbable phases.
Bone apatite is not pure hydroxyapatite (CA 10 ((PO 4 ) 6 OH 2 ). It contains about 6 weight% (wt%) of carbonate ions (CO 3 2-) as well as other trace elements such as Mg 2+ , Fe 2+ , Na + , HPO 4 2-, F -and CI -. 11 In terms of its chemical properties, carbonate-containing apatite resembles bone apatite more than pure HA, but it is non-stoichiometric and many investigators have been reluctant to use it for sintering. 12 Non-stoichiometric apatite is likely to produce undesirable thermal by-products, such as tricalcium phosphate, calcium oxide, or tetracalcium phosphate, when heated to over 1100˚C or during sintering. 13, 14 We have successfully developed sintered carbonate apatite (CA). In our previous in vitro study, we found that sintered CA was resorbed by osteoclasts whereas sintered HA was not. 15 Our aim in this study was to evaluate osteoconduction and bioresorption by CA in vivo.
Materials and Methods
We synthesised CA and HA as described previously, 13 by mixing 2 l of a 1 mol/l solution of calcium nitrate and 2 l of a 0.15 mol/l solution of disodium hydrogen phosphate con- taining 6 and 0 mols of disodium carbonate, respectively, for three days at 100˚C and pH 9.0 ± 0.1. The slurry was centrifuged, the supernatant decanted, and the centrifugation washed ten times with deionised double-distilled water. The CA had a carbonate content of about 12 wt%. CA and HA particles between 300 and 500 µm in size were placed with a little slurry and set aside after the synthesis in cylindrical moulds made of paper. They were then dried in air. The sintered CA and sintered HA were produced by heating the samples in a platinum crucible in an electric furnace (Nikkato Corp, Tokyo, Japan) for two hours at 750˚C and 1200˚C, respectively, with a temperature increase and subsequent decrease of 5˚C/min. No phases other than apatite were detected by x-ray diffraction (XD-3A; Shimadzu Co Ltd, Kyoto, Japan) in the samples after sintering (Fig. 1) . The diffraction patterns were identical except for the somewhat greater overlap of the two reflections around 32˚ 2 θ in the pattern for the sintered CA. This poorer resolution suggested that sintered CA was somewhat low in crystallinity. In the infrared spectrum (FTIR-4200, Shimadzu Co Ltd) ( Fig.  2) , the broad doublet bands at 1410 and 1460 cm -1 and the band at 875 cm -1 , which were characteristic of carbonate substituted for PO 4 (type B carbonate apatite), 16 were clearly observed in the sintered CA. The concentration of carbonate of sintered samples, calculated from spectra recorded in the linear absorption mode, was approximately 6 wt%, which Photomicrograph showing newly-formed bone around CA after one month (CA, carbonate apatite; B, newly formed bone; arrows indicate the pores).
(haematoxylin and eosin x20).
Fig. 5
Photomicrograph showing increased bone growth into and around CA with bioresorption after three months (CA, carbonate apatite; B, newly formed bone; haematoxylin and eosin x20).
Fig. 3
Scanning electron micrograph of sintered CA before implantation.
was similar to the amount of carbonate in bone apatite. The size of the cylindrical porous material was 4 mm in diameter and 4 mm in height. The porosity was approximately 20% and the mean pore size was 175 µm. When examined by SEM (JSM-35C; JEOL, Tokyo, Japan), CA appeared to be composed of grains ranging in size from 0.3 to 1.0 µm (crystal size 0.01 µm) (Fig. 3) , whereas HA had grains about ten times larger (crystal size 0.1 µm). The mechanical properties of CA were similar to those of HA. 17 The compressive strength was about 500 MPa, the bending strength 95 ± 5 MPa, and the fracture toughness 0.76 ± 0.09 MPa⋅m 1/2 . We used 36 mature female Japanese white rabbits, weighing between 3.0 and 4.0 kg. Under anaesthesia with intravenous pentobarbital sodium (Nembutal, 20 mg/kg body-weight; Abbot Laboratories, North Chicago, Illinois) a medial longitudinal incision was made and the distal femur exposed without arthrotomy. A bone defect (4 x 4 mm) was generated using a drill in the distal metaphysis of the femur perpendicular to the long axis in a sagittal direction. Bone debris was carefully removed by saline irrigation. The defect in one knee was filled tightly with either sterile CA or sterile HA while that in the other received sterile CA or was left empty as a control. The wound was then closed in layers. After the operation, all rabbits were allowed free activity in the cage without immobilisation.
At 1, 3, 6 and 12 months after operation nine rabbits, three from each group, were killed by an overdose of pentobarbital sodium. The distal femur was removed and the defects with or without the implant were evaluated by microfocus CT (MFX-CT; Andrex MX-4, Japan Fine Ceramics Centre, Nagoya, Japan) without destruction of the samples before sectioning for histological examination. The MFX-CT has a spatial resolution of the order of 10 µm, which is approximately 10 to 20 times finer than that of the usual conventional CT systems. This level of resolution gives CT images comparable with those obtained by contact microradiography with sectioned specimens. Six MFX-CT images were measured in perpendicular planes to each defect. For light microscopy the femur was fixed with 10% formalin, dehydrated in alcohol series and for undecalcified histological evaluation, the samples were embedded in methylmethacrylate. Sections 7 µm in thickness were prepared from the centre of the defects and stained with Toluidine Blue. For decalcified histological evaluation, the samples were decalcified in EDTA and embedded in paraffin. Sections 5 µm in thickness were prepared and stained with haematoxylin and eosin (HE) and tartrate-resistant acid phosphatase (TRAP) after pre-treatment with cyanuric chloride. 18 Light microscopy was carried out at magnifications of 40, 100, 200 and 400 times and six fields were examined to observe the entire section. The sections were examined blindly by a single observer (MH) without knowledge of the time after operation.
We carried out quantitative analysis of bioresorption and bone ingrowth as well as porosity (total pore area/total area) using NIH Image software on microfocus CT images captured on an Apple Macintosh computer. The quantity of regenerated bone in the pores of the materials or defect was expressed as a percentage (total bone area/total pore area or total area of defect) as was that around the materials (length of bone contact/length of implant surface line). Statistical analysis. This was performed using the MannWhitney U test or the Kruskal-Wallis test. The level of significance was p < 0.05.
Results
No implant was lost as a result of infection. We observed bone growth around CA and HA after one month (Fig. 4) . Newly-formed bone was placed in direct contact with the materials. After three months we found bone ingrowth in the pores of both CA and HA (Figs 5 and 6 ). Osteogenesis Photomicrograph showing osteoclast-like cells (arrows) and osteoblasts (TRAP x200). Photomicrograph of increased bone growth into and around HA after three months. Most HA was removed by decalcification, producing an empty white area (*) (B, newly-formed bone; haematoxylin and eosin x20).
occurred through an intramembranous process and the implants were mostly surrounded by lamellar bone after six months. Bone ingrowth into and around the materials increased significantly from one to three months in both CA and HA (Table I) . We could detect no differences in terms of bone ingrowth into and around CA and HA at the same periods. Multinucleated cells were observed on the surface of CA as well as at the interface of CA and bone at 3, 6 and 12 months after operation. These cells were TRAP-positive and designated as osteoclast-like cells. They invaded the pores and osteoblasts formed new bone simultaneously, showing incorporation in the bone-remodelling process (Fig. 7) In the HA group no osteoclast-like cells were detected. None of the specimens showed any obvious inflammatory reaction.
The porosity of CA increased significantly from one to three months and from three to six months, reaching approximately 50%, being 2.5 times as much as the original pore. This indicated bioresorption of the material. HA showed no substantial loss of the material, indicating no biodegradation (Figs 8 and 9 ). The porosity of CA was greater than that of HA after 3, 6 and 12 months (p = Representative microfocus CT scans of CA and HA showing CA after one (a) and six months (b) and HA after six months (c). The implant material (light, high-density (I) and newly-formed bone (dark B) can be identified by different levels of grey. A low-density area indicated a pore without newlyformed bone (P). There is increasing bone density in both CA and HA as well as increasing porosity in CA. 0.009). In the control samples the defects were filled with inadequate bone and fibrous tissue, and no complete repair was obtained. The quantity of regenerated bone in the defects was only 17% even after 12 months.
Discussion
There have been many studies of the bone-bonding and bioresorption characteristics of calcium phosphates such as hydroxyapatite and β-tricalcium phosphate. Their bioresorption can be divided into solution-mediated processes when the implant dissolves in physiological solutions, and cell-mediated processes, namely phagocytosis. 19 Since biological fluids are supersaturated with respect to apatite in vivo, solution-mediated processes may not occur unless biological fluids become acidified. When the apatite evokes a local inflammation, the ruffled border of the osteoclast releases H + and the environment around the apatite becomes acidified. 20, 21 .Bioresorption is important for the physiology of bone tissues after substitution with biomaterials. In order to synthesise sintered stoichiometric HA, we have to heat the material to over 1100˚C. Heating over such a high temperature dramatically increases its crystallinity, reducing its solubility in acid solutions. The sintering temperature for CA containing 12 wt% carbonate was about 400˚C lower than that needed for HA. The carbonate-containing apatite expanded when temperatures were further raised over 800˚C, probably because of the evolution of carbon dioxide from the specimen. 14 The best sintering occurred when the carbonate-containing apatite was kept at temperatures of between 600 and 800˚C, preferably around 750˚C when shrinkage was greatest. 13 In our previous in vitro study, sintered CA and deproteinated bone rapidly dissolved to an appreciable extent in an acid media (10 m mol/l acetic acid, pH 5.0). On the other hand, it took 3.8 days for the composition of the solution for sintered HA to be comparable with that for sintered CA at 30 seconds with respect to the degree of saturation. These findings indicate the extreme difficulty in dissolving sintered HA. Regarding solubility, sintered CA can be favourably compared with β-tricalcium phosphate. 22 The presence of carbonate in the apatite lattice makes the sintering temperature decrease and the crystallinity lower. The stability of the apatite structure decreases and reactivity towards acid dissolution increases 12 which would contribute to resorption in bony tissue. Thus, sintered CA may more closely resemble bone apatite. β-tricalcium phosphate was more resorbable than HA and demonstrated osteoconduction, osteoclast-like cell-based resorption and no inflammation. 7, 23, 24 By contrast, Klein et al 25 found that β-tricalcium phosphate was likely to be phagocytosed by macrophages, evoking a local inflammatory response because of its foreign-body reaction. For use as a scaffold for bone defects, it is desirable to develop more soluble sintered apatites, which are resorbed in bone tissues during cell-mediated remodelling without inflammation.
We found bioresorption of CA by osteoclast-like cells; CA was incorporated in the bone remodelling process because resorption by osteoclast-like cells and osteogenesis by osteoblasts occurred simultaneously. CA was resorbed from over one to six months, but no further resorption was found from six to 12 months. Overgaard et al 26 suggested that there were two phases of resorption of calcium phosphate. Phase I was characterised by fast loss and phase II by slow loss. Phase II began when the implant was stabilised and the fibrous tissue membrane was converted to bone. It has been suggested that the size of the crystal is important in the degradation of HA. 4 The HA used in our study (crystal size, 0.1 µm) was not resorbed. The differentiation of osteoclasts may require a degradable substrate such as bone or a bioactive implant with similar properties. The rates of resorption and dissolution of sintered HA may be much slower for bone remodelling compared with those of sintered CA. 27 Sintered CA seems to have satisfactory osteoconductive and bioresorption characteristics in this experiment and therefore is useful as a bioresorbable bone substitute. The bioresorbable performance of sintered CA may result from the similarities of its composition and nanostructure to those of bone. Further evaluation is needed to develop completely resorbable CA.
